BRIEF-Roche receives 510(K) clearance from FDA for treponema pallidum assay

* Roche receives 510(K) clearance from FDA for Treponema Pallidum assay to aid Clinicians in the diagnosis of Syphilis infection Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.